In hepatocellular carcinoma cells, sulfo-N-succinimidyl oleate (SSO) reduces the EMT phenotype and decreases the migration rate of PA-treated cells by inhibiting CD36 [151]. This evidence concerns the gene CD36 and hepatocellular carcinoma.